Bipolar II and Families (1 CE)
This course is for: Clinical Psychologists and Counselors
Course By: Julie Laken Harnisher, Ph.D.
Content By: Fisher, A., Sharpe, L., Anderson, J., Manicavasagar, V., & Juraskova, I. (2018). Development and pilot of a decision-aid for patients with bipolar II disorder and their families making decisions about treatment options to prevent relapse. PLoS ONE, 13(7), 1-22.
Course Description: A diagnosis of bipolar II disorder (BPII) is accompanied by a need to make complex treatment decisions about mood-stabilizing medications and adjunctive psychological therapies. Treatment decisions for bipolar II disorder are multi-faceted and should take into account patient preferences along with the risks and benefits of each treatment protocol. Researchers concluded that patients and their families found the decision aid to be informative, balanced, helpful, and easy to use in the treatment planning process. Overall, assessed factors related to both qualities of the decision-making process (e.g., decisional conflict) and outcomes (e.g., knowledge and values-concordant choice) confirmed the potential usefulness of the decision-aids for supporting informed BPII treatment choices.
- Identify the 2 study aims and the methods related to treatment decision aids for BPII patients and their families
- Analyze the data by exploring the statistical tests used in conjunction with the discussed findings
- Integrate the limitations of the current study with the identified areas for future research
- Read and understand Development and pilot of a decision-aid for patients with bipolar II disorder and their families making decisions about treatment options to prevent relapse
- Read the Course Description and Learning Objectives
- Consider the factors related to treatment decision-aids coupled with the statistical findings from the accompanying article
- Work through the post-test questions; answer selections should be derived from the accompanying article
- Return to the referenced article for any missed questions and/or to further understand the relationship between patients diagnosed with BPII disorder and their families when making evidenced-based treatment decisions